Acasti pharma ceo to present at the 32nd annual oppenheimer healthcare conference on march 16th

Laval, quebec, march 09, 2022 (globe newswire) -- acasti pharma inc. (“acasti” or the “company”) (nasdaq: acst and tsx-v: acst), today announced that jan d'alvise, president and chief executive officer of acasti pharma will be presenting at the 32nd annual oppenheimer healthcare conference being held virtually march 15-17, 2022.
ACST Ratings Summary
ACST Quant Ranking